294 related articles for article (PubMed ID: 18213512)
21. Structural characterisation of the catalytic domain of botulinum neurotoxin X - high activity and unique substrate specificity.
Masuyer G; Zhang S; Barkho S; Shen Y; Henriksson L; Košenina S; Dong M; Stenmark P
Sci Rep; 2018 Mar; 8(1):4518. PubMed ID: 29540745
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure of the catalytic domain of botulinum neurotoxin subtype A3.
Leka O; Wu Y; Li X; Kammerer RA
J Biol Chem; 2021; 296():100684. PubMed ID: 33891946
[TBL] [Abstract][Full Text] [Related]
23. Residues glutamate 216 and aspartate 301 are key determinants of substrate specificity and product regioselectivity in cytochrome P450 2D6.
Paine MJ; McLaughlin LA; Flanagan JU; Kemp CA; Sutcliffe MJ; Roberts GC; Wolf CR
J Biol Chem; 2003 Feb; 278(6):4021-7. PubMed ID: 12446689
[TBL] [Abstract][Full Text] [Related]
24. Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B.
Swaminathan S; Eswaramoorthy S
Nat Struct Biol; 2000 Aug; 7(8):693-9. PubMed ID: 10932256
[TBL] [Abstract][Full Text] [Related]
25. Crystal structure of botulinum neurotoxin type G light chain: serotype divergence in substrate recognition.
Arndt JW; Yu W; Bi F; Stevens RC
Biochemistry; 2005 Jul; 44(28):9574-80. PubMed ID: 16008342
[TBL] [Abstract][Full Text] [Related]
26. Analysis of active site residues of botulinum neurotoxin E by mutational, functional, and structural studies: Glu335Gln is an apoenzyme.
Agarwal R; Binz T; Swaminathan S
Biochemistry; 2005 Jun; 44(23):8291-302. PubMed ID: 15938619
[TBL] [Abstract][Full Text] [Related]
27. Catalytic role for arginine 188 in the C-C hydrolase catalytic mechanism for Escherichia coli MhpC and Burkholderia xenovorans LB400 BphD.
Li C; Li JJ; Montgomery MG; Wood SP; Bugg TD
Biochemistry; 2006 Oct; 45(41):12470-9. PubMed ID: 17029402
[TBL] [Abstract][Full Text] [Related]
28. Botulinum neurotoxin types B and E: purification, limited proteolysis by endoproteinase Glu-C and pepsin, and comparison of their identified cleaved sites relative to the three-dimensional structure of type A neurotoxin.
Prabakaran S; Tepp W; DasGupta BR
Toxicon; 2001 Oct; 39(10):1515-31. PubMed ID: 11478959
[TBL] [Abstract][Full Text] [Related]
29. Substrate recognition strategy for botulinum neurotoxin serotype A.
Breidenbach MA; Brunger AT
Nature; 2004 Dec; 432(7019):925-9. PubMed ID: 15592454
[TBL] [Abstract][Full Text] [Related]
30. Structural characterization of three novel hydroxamate-based zinc chelating inhibitors of the Clostridium botulinum serotype A neurotoxin light chain metalloprotease reveals a compact binding site resulting from 60/70 loop flexibility.
Thompson AA; Jiao GS; Kim S; Thai A; Cregar-Hernandez L; Margosiak SA; Johnson AT; Han GW; O'Malley S; Stevens RC
Biochemistry; 2011 May; 50(19):4019-28. PubMed ID: 21434688
[TBL] [Abstract][Full Text] [Related]
31. Glycine insertion at protease cleavage site of SNAP25 resists cleavage but enhances affinity for botulinum neurotoxin serotype A.
Ho M; Goh CH; Brothers MC; Wang S; Young RL; Ou Y; Lui JN; Kalafatis M; Lan X; Wolf AE; Rienstra CM; Wilson BA
Protein Sci; 2012 Mar; 21(3):318-26. PubMed ID: 22170566
[TBL] [Abstract][Full Text] [Related]
32. The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction.
Rummel A; Mahrhold S; Bigalke H; Binz T
Mol Microbiol; 2004 Feb; 51(3):631-43. PubMed ID: 14731268
[TBL] [Abstract][Full Text] [Related]
33. High Yield Preparation of Functionally Active Catalytic-Translocation Domain Module of Botulinum Neurotoxin Type A That Exhibits Uniquely Different Enzyme Kinetics.
Dhaliwal HK; Thiruvanakarasu N; Kumar R; Patel K; Ambrin G; Cai S; Singh BR
Protein J; 2017 Dec; 36(6):489-501. PubMed ID: 29030733
[TBL] [Abstract][Full Text] [Related]
34. The structural basis for the perturbed pKa of the catalytic base in 4-oxalocrotonate tautomerase: kinetic and structural effects of mutations of Phe-50.
Czerwinski RM; Harris TK; Massiah MA; Mildvan AS; Whitman CP
Biochemistry; 2001 Feb; 40(7):1984-95. PubMed ID: 11329265
[TBL] [Abstract][Full Text] [Related]
35. Investigation of the catalytic site within the ATP-grasp domain of Clostridium symbiosum pyruvate phosphate dikinase.
Ye D; Wei M; McGuire M; Huang K; Kapadia G; Herzberg O; Martin BM; Dunaway-Mariano D
J Biol Chem; 2001 Oct; 276(40):37630-9. PubMed ID: 11468288
[TBL] [Abstract][Full Text] [Related]
36. Multiple pocket recognition of SNAP25 by botulinum neurotoxin serotype E.
Chen S; Barbieri JT
J Biol Chem; 2007 Aug; 282(35):25540-7. PubMed ID: 17609207
[TBL] [Abstract][Full Text] [Related]
37. Botulinum neurotoxin type A: limited proteolysis by endoproteinase Glu-C and alpha-chymotrypsin enhanced following reduction; identification of the cleaved sites and fragments.
Beecher DJ; DasGupta BR
J Protein Chem; 1997 Oct; 16(7):701-12. PubMed ID: 9330228
[TBL] [Abstract][Full Text] [Related]
38. Substrate binding mode and its implication on drug design for botulinum neurotoxin A.
Kumaran D; Rawat R; Ahmed SA; Swaminathan S
PLoS Pathog; 2008 Sep; 4(9):e1000165. PubMed ID: 18818739
[TBL] [Abstract][Full Text] [Related]
39. The choline binding site of phospholipase C (Bacillus cereus): insights into substrate specificity.
Martin SF; Follows BC; Hergenrother PJ; Trotter BK
Biochemistry; 2000 Mar; 39(12):3410-5. PubMed ID: 10727235
[TBL] [Abstract][Full Text] [Related]
40. Association of botulinum neurotoxin serotype A light chain with plasma membrane-bound SNAP-25.
Chen S; Barbieri JT
J Biol Chem; 2011 Apr; 286(17):15067-72. PubMed ID: 21378164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
